BIO Operating Cash Flow
$492.60MTTM · USD
Period ending:
BIO FY Operating Cash FlowUSD
$669.46M$0.00
1989-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
BIO operating cash flow history
Cash generated from core business operations. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| 532,200,000 | |
| 455,200,000 | |
| 374,943,000 | |
| 194,447,000 | |
| 669,464,000 | |
| 584,972,000 | |
| 457,897,000 | |
| 285,494,000 | |
| 104,137,000 | |
| 216,066,000 | |
| 186,210,000 | |
| 273,312,000 | |
| 169,136,000 | |
| 266,480,000 | |
| 262,735,000 | |
| 225,909,000 | |
| 325,074,000 | |
| 191,371,000 | |
| 191,580,000 | |
| 118,229,000 | |
| 108,284,000 | |
| 123,093,000 | |
| 127,640,000 | |
| 105,758,000 | |
| 99,495,000 | |
| 24,247,000 | |
| 45,000,000 | |
| 27,300,000 | |
| 21,100,000 | |
| 33,200,000 | |
| 38,200,000 | |
| 48,300,000 | |
| 22,500,000 | |
| 4,000,000 | |
| 4,100,000 | |
| 12,100,000 | |
| 9,800,000 |
Compare operating cash flow
Other companies in —. Each page shows its own reporting periods and currency.
- Taiwan Semiconductor Manufacturing Company Ltd. (TSM) operating cash flow
- Shell PLC American Depositary Shares (each representing two (2) Ordinary Shares) (SHEL) operating cash flow
- Novartis AG Common Stock (NVS) operating cash flow
- Royal Bank Of Canada Common Stock (RY) operating cash flow
- Alibaba Group Holding Limited American Depositary Shares each representing eight Ordinary share (BABA) operating cash flow
- SAP SE ADS (SAP) operating cash flow
- AstraZeneca PLC Ordinary Shares (AZN) operating cash flow
- Toyota Motor Corporation Common Stock (TM) operating cash flow
All BIO financial metrics · BIO stock overview · How to interpret financial metrics
